ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 163 filers reported holding ANI PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $59,000 | +20.4% | 1,113 | +5.3% | 0.00% | 0.0% |
| Q2 2017 | $49,000 | -5.8% | 1,057 | +1.9% | 0.00% | 0.0% |
| Q1 2017 | $52,000 | -14.8% | 1,037 | +2.7% | 0.00% | -50.0% |
| Q4 2016 | $61,000 | -9.0% | 1,010 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $67,000 | +28.8% | 1,010 | +9.3% | 0.00% | 0.0% |
| Q2 2016 | $52,000 | +73.3% | 924 | +3.6% | 0.00% | +50.0% |
| Q1 2016 | $30,000 | -34.8% | 892 | -12.4% | 0.00% | 0.0% |
| Q4 2015 | $46,000 | +9.5% | 1,018 | -3.0% | 0.00% | 0.0% |
| Q3 2015 | $42,000 | -28.8% | 1,050 | +10.5% | 0.00% | 0.0% |
| Q2 2015 | $59,000 | -56.6% | 950 | -56.2% | 0.00% | -60.0% |
| Q1 2015 | $136,000 | – | 2,168 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |